Sprycel

BMS’ long-standing leukemia blockbuster stares down its first generic
Pharma Voice
Fri, 07/12/24 - 11:10 am
Bristol Myers Squibb
Sprycel
leukemia
generics
CML
Xspray Pharma
Xspray, seeking FDA approval for its Sprycel competitor, settles patent lawsuit with BMS
Fierce Pharma
Tue, 09/12/23 - 07:08 pm
Xspray Pharma
FDA
Sprycel
Bristol Myers Squibb
Dasynoc
FDA rejects Xspray's would-be rival to Bristol Myers' Sprycel on dosing, manufacturing concerns
Fierce Pharma
Wed, 07/12/23 - 09:35 am
Xspray Pharma
Eversana
Sprycel
Bristol Myers Squibb
Dasynoc
leukemia
Using Bristol-Myers’ popular leukemia drug to improve anti-PD-1 cancer immunotherapy
Fierce Biotech
Wed, 02/20/19 - 08:00 pm
cancer
Cedars Sinai
Bristol-Myers Squibb
Sprycel
anti-PD-L1
New Class of Breast Cancer Drugs Could Help Treat Toughest Lung Cancer Cases
BioSpace
Fri, 12/28/18 - 01:30 pm
breast cancer
lung cancer
AstraZeneca
Tagrisso
Novartis
Gleevec
Tasigna
Bristol-Myers Squibb
Sprycel
Pfizer
Bosulif
Takeda
Iclusig
The FDA Accepts Bristol-Myers Squibb’s Application for Sprycel in Ph+ Acute Lymphoblastic Leukemia
CP Wire
Thu, 08/30/18 - 10:16 am
Bristol-Myers Squibb
Sprycel
acute lymphoblastic leukemia
FDA
The FDA Accepts Bristol-Myers Squibb’s Application for Sprycel in Ph+ Acute Lymphoblastic Leukemia
Thu, 08/30/18 - 09:44 am
Bristol-Myers Squibb
Sprycel
acute lymphoblastic leukemia
Two drug makers complain India is thwarting licenses for selling generics
Stat
Wed, 04/13/16 - 11:46 am
India
Lee Pharma
BDR Pharma
generics
Sprycel
Bristol-Myers Squibb
AstraZeneca
Onglyza
The top 10 most expensive drugs of 2013
Fierce Pharma
Tue, 10/14/14 - 10:05 am
drug pricing
Soliris
Alexion
Naglazyme
Biomarin
Kalydeco
Vertex
Cinryze
Shire
Sprycel
Bristol-Myers Squibb
Pomalyst
Celgene
Xyrem
Jazz Pharmaceuticals
Erbitux
Merck KGaA
Revlimid
Questcor
Mallinckrodt
H.P. Acthar Gel
Tackling Cancer: Leukemia's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/20/13 - 11:40 am
leukemia
Sprycel
Bristol-Myers Squibb
Gleevec
Novartis
Iclusig
Ariad Pharmaceuticals
Bosulif
Pfizer
Erwinaze
Jazz Pharmaceuticals
Idelalisib
Gilead
ibrutinib
Pharmacyclics
Can Bristol-Myers Squibb Compete In Immuno-Oncology?
Seeking Alpha
Mon, 04/8/13 - 11:03 am
immuno-oncology
cancer
Bristol-Myers Squibb
AbbVie
Ariad Pharmaceuticals
JNJ
Eli Lilly
Novartis
Pfizer
Medivation
Erbitux
Yervoy
Sprycel
Orencia
Bristol-Myers launches patient management programs for Sprycel patients
The Fly on the Wall
Wed, 08/15/12 - 11:04 am
Sprycel
leukemia
Bristol-Myers Squibb
Otsuka, Bristol-Myers Squibb announce six-year data from SPRYCEL Phase 3 trial on CP-CML
news-medical.net
Sat, 06/16/12 - 02:12 pm
Otsuka
Bristol-Myers Squibb
Sprycel
leukemia
chronic myeloid leukemia
FDA Warns Bristol Myers Leukemia Drug Could Cause Hypertension
FOX Business
Tue, 10/11/11 - 10:47 am
FDA
warnings
Bristol-Myers Squibb
leukemia
Sprycel
Five-Year Follow-Up Data for SPRYCEL® (dasatinib) 100 mg Once Daily Demonstrated 78 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukemia Resistant or Intolerant to Gleevec®*
BusinessWire
Sat, 06/4/11 - 10:53 am
Sprycel
Bristol-Myers Squibb
leukemia
Bristol-Myers Squibb: Outstanding Pipeline Makes It Most Attractive Among Large Pharmaceuticals
Seeking Alpha
Fri, 02/25/11 - 12:06 am
pipelines
Bristol-Myers Squibb
Reyataz
HIV
Baraclude
Orencia
rheumatoid arthritis
Sprycel
chronic myeloid leukemia
Onglyza
diabetes
hepatitis B
FDA expands approval of Bristol-Myers leukemia drug to patients newly diagnosed with disease
Yahoo/AP
Thu, 10/28/10 - 10:07 pm
leukemia
Sprycel
Bristol-Myers Squibb
Bristol-Myers gets drug approvals, awaits more
Yahoo/AP
Sat, 10/23/10 - 12:42 pm
Bristol-Myers Squibb
pegylated interferon lambda
hepatitis C
Sprycel
chronic myeloid leukemia
Onglyza
Bristol-Myers gets drug approvals, awaits more
Yahoo/AP
Sat, 10/23/10 - 10:42 am
Bristol-Myers Squibb
ipilimumab
Sprycel
SPRYCEL® (dasatinib) Receives FDA Priority Review for the Treatment of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia (CML) in Chronic Phase
Yahoo/BusinessWire
Sat, 07/10/10 - 11:39 am
Sprycel
chronic myeloid leukemia
BMS
Otsuka

Pages